Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring
Status:
Active, not recruiting
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety, pharmacokinetics and pharmacodynamics of,
and the tolerability and acceptance of an intravaginal ring (IVR) delivering both tenofovir
and levonorgestrel (TFV/LNG) and an IVR delivering TFV only, compared to a placebo IVR, in
women in Western Kenya.
Phase:
Phase 2
Details
Lead Sponsor:
CONRAD
Collaborators:
Centers for Disease Control and Prevention Kenya Medical Research Institute University of Washington